Refine Results
- Products
-
Product Category
- Applications and Industries
-
- Content Type
-
Content Type
- Unit Quantity
-
Unit Quantity
- Research Area
-
Research Area
No results found for “XXX”
Try modifying your search
- Try to search without any filters
- Try different keywords
- Try more general and fewer keywords
- Make sure all keywords are spelled correctly
- Analysis Platform
-
Analysis Platform
- Author
-
Author
- Journal
-
Journal
No results found for “XXX”
Try modifying your search
- Try to search without any filters
- Try different keywords
- Try more general and fewer keywords
- Make sure all keywords are spelled correctly
- Language
-
Language
Visit us at Leopold-Ungar-Platz 2 1190 Wien Österreich / Austria
Contact Us page for Agilent Technologies Luxembourg
Small molecule-induced protein degradation is a promising modality in novel, highly targeted cancer therapy development and beyond. Within this realm, Monte Rosa Therapeutics in Boston, Massachusetts, has particular expertise working with small...
Reach out to us at ido_info@agilent.com, Field Support Center for Europe, Middle East and Africa.
Normal human cells contain 23 chromosome pairs, each encoding the genetic information of life as well as passing on inheritable traits from parents. Chromosomes are tightly folded into origami-like structures that are mind-boggling in their...
Explore a comprehensive portfolio of sample-to-data cell therapeutic development solutions that work seamlessly together to provide reliable results. Find application notes, webinars, and more.
Contact Us page for Agilent Technologies Caribbean Islands
Visit us at Hewlett-Packard-Str. 8, D-76337 Waldbronn. Reach out to us at customercare_germany@agilent.com or call +49 (0)7243-602-0.
Visit us at Parc Technopolis / Z.A. Courtaboeuf 3, Avenue du Canada CS 90263 91978 LES ULIS Cedex Tel: +33 (0)1 64 53 60 00
Contact Us page for Agilent Technologies Finland
Infographic highlighting the Agilent workflows for cell and molecular biology for drug research.
- Publication Part Number: 5994-8016EN
- Created: 01 Dec 2024
- 8 MB
TGF-β/SMAD signaling is quantitatively evaluated in biochemical, cellular, and spheroid-based assays using a cancer model of epithelial-to-mesenchymal transition.
- Publication Part Number: 5994-7240EN
- Created: 13 Mar 2024
- 3 MB
Contact Us page for New Zealand
Reach out to us at ido_info@agilent.com, Field Support Center for Europe, Middle East and Africa.
Reach out to us at ido-generic-email-customerservice@agilent.com
Shortly after the first full genome sequence of the yeast Saccharomyces cerevisiae was completed in the mid-1990s, Dr. Corey Nislow remembers feeling a bit disheartened that this information didn’t shed any additional light on how the yeast actually...
Contact Us page for Philippines
Contact Us page for Agilent Technologies Guinea Bissau
Reach out to us at ido_info@agilent.com, Field Support Center for Europe, Middle East and Africa.
Reach out to us at ido_info@agilent.com, Field Support Center for Europe, Middle East and Africa.